1 / 11

Overview of B&W Medical Isotope Production System

Overview of B&W Medical Isotope Production System. Foundation for Nuclear Studies September 27, 2011. Steve Schilthelm Deputy Program Manager. The Babcock & Wilcox Company. Government Operations. Power Generation Systems. B&W Technical Services Group, Inc.

henry
Download Presentation

Overview of B&W Medical Isotope Production System

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Overview of B&W Medical Isotope Production System Foundation for Nuclear Studies September 27, 2011 Steve Schilthelm Deputy Program Manager

  2. The Babcock & Wilcox Company Government Operations Power Generation Systems B&W TechnicalServices Group, Inc. B&W NuclearOperations Group, Inc. B&W Power Generation Group, Inc. B&W NuclearEnergy , Inc. Manages and operates high-consequence facilities, provides technical services and support to government agencies and private customers Manufactures nuclear components for U.S. Department of Energy Manufactures and services coal, biomass, CNG, concentrated solar power plant equipment, & Nox, Sox, mercury scrubbers Manufactures commercial nuclear components and provides services to commercial nuclear market High-Consequence Operations & Services Advanced Engineering and Manufacturing

  3. Covidien Reach Extends Globally and Locally 20,000+ U.S. employees, 41,000+ worldwide Diverse healthcare products used in all clinical settings Products manufactured in 17 states Nuclear Medicine: One of two U.S. suppliers of technetium 99m (Tc 99m) Image used by permissionof Covidien Covidien Tc 99m-based products sold in all 50 states

  4. B&W MIPS – 99Mo Production Using Aqueous Homogeneous Reactor • Market studies in Late 1990s • Patented in 1997 (Dr. Russell M. Ball) • 2007 MIPS project re-initiated • 2009 Agreement with Covidien • 2009 Cooperative Agreement with NNSA • Non-proliferation (LEU) • Domestic supply AHR using LEU offers safety, safeguards, simplicity and waste advantages

  5. CLEVELAND, OH CLEVELAND, OH AHRs are not New Technology SHEBA Reactor, LANL Over 30 AHRs Built and Operated

  6. AHR - America’s First University Reactor N.C. State’s – R1 (1953-73)

  7. Traditional Technology Transport Transport Transport Transport 235U Target Fabrication Target Irradiation: Several days Reactor: 10,000 -100,000 kilowatts 99mTc User Medical Facilities Dissolved Target Waste with 235U 99mTc Generator Facility 99Mo Processing Facility

  8. B&W MIPS Technology Transport Transport 99mTc User Medical Facilities MIPS Facility AHR Reactor 240 kilowatts- 5 days Initial Fuel Solution Preparation • Reactor fuel/target solution returned for subsequent irradiation 99mTc Generator Facility 99Mo Processing Cells

  9. Completing R&D Phase of Project • National Laboratories • Argonne • Los Alamos • Armed Forces Radiobiology Research Institute, MD • Purdue University • B&W Labs, VA • INVAP, Argentina

  10. MIPS Project Progress • Conceptual design complete • NRC licensing and waste policy decisions complete • Environmental analysis prepared • Completing R&D activities • Following legislation (HR 3276, S 99) • Entering detailed design and licensing phase of the project

  11. B&W MIPS Summary • Mo-99 production using LEU AHR results in: • Increased efficiency • Reducedwaste • No proliferation concerns • Safe operation • Stable domestic supply

More Related